Yixintang Pharmaceutical Group Co., Ltd. (SHE:002727)

China · Delayed Price · Currency is CNY

10.79

-0.12 (-1.10%)

Sep 16, 2026, 3:04 PM CST

Market Cap	6.19B -28.0%
Revenue (ttm)	16.89B -4.1%
Net Income	270.63M +230.5%
EPS	0.47 +240.1%
Shares Out	574.13M
PE Ratio	22.75
Forward PE	14.70
Dividend	0.40 (3.67%)
Ex-Dividend Date	May 29, 2026

Volume	4,856,650
Open	11.08
Previous Close	10.91
Day's Range	10.70 - 11.08
52-Week Range	9.41 - 15.10
Beta	0.57
Analysts	Buy
Price Target	13.19 (+22.24%)
Earnings Date	Aug 27, 2026

About SHE:002727

Yixintang Pharmaceutical Group Co., Ltd., together with its subsidiary, engages in the pharmaceutical retail chain and pharmaceutical distribution business. The company is involved in the wholesale, retail, leasing, and operation of medical devices; sale of food, disinfectants, disinfection equipment, and disposable medical products, household appliances, adult toys, agricultural and sideline products, cosmetics, and daily sundries and necessities; manufacturing of glasses; provision of value-added telecommunications, Internet live broadcast te... [Read more]

Industry Pharmaceutical Retailers

Sector Healthcare

Founded 2000

Employees 34,848

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 002727

Full Company Profile

Financial Performance

In 2025, SHE:002727's revenue was 17.34 billion, a decrease of -3.69% compared to the previous year's 18.00 billion. Earnings were 263.43 million, an increase of 130.80%.

Financial Statements

Analyst Summary

According to 5 analysts, the average rating for 002727 stock is "Buy." The 12-month stock price target is ¥13.19, which is an increase of 22.24% from the latest price.

Price Target

¥13.19

(22.24% upside)

Analyst Consensus: Buy

Stock Forecasts